Department of Immunology, Mayo Clinic, Rochester, United States
Michael Jeremy Shapiro
Department of Immunology, Mayo Clinic, Rochester, United States
Shaylene A McCue
Department of Immunology, Mayo Clinic, Rochester, United States
Madeleine M Kennedy
Department of Immunology, Mayo Clinic, Rochester, United States
Matthew J Rajcula
Department of Immunology, Mayo Clinic, Rochester, United States
Hu Zeng
Department of Immunology, Mayo Clinic, Rochester, United States; Division of Rheumatology, Department of Medicine, Mayo Clinic, Rochester, United States
After antigenic activation, quiescent naive CD4+ T cells alter their metabolism to proliferate. This metabolic shift increases production of nucleotides, amino acids, fatty acids, and sterols. Here, we show that histone deacetylase 3 (HDAC3) is critical for activation of murine peripheral CD4+ T cells. HDAC3-deficient CD4+ T cells failed to proliferate and blast after in vitro TCR/CD28 stimulation. Upon T-cell activation, genes involved in cholesterol biosynthesis are upregulated while genes that promote cholesterol efflux are repressed. HDAC3-deficient CD4+ T cells had reduced levels of cellular cholesterol both before and after activation. HDAC3-deficient cells upregulate cholesterol synthesis appropriately after activation, but fail to repress cholesterol efflux; notably, they overexpress cholesterol efflux transporters ABCA1 and ABCG1. Repression of these genes is the primary function for HDAC3 in peripheral CD4+ T cells, as addition of exogenous cholesterol restored proliferative capacity. Collectively, these findings demonstrate HDAC3 is essential during CD4+ T-cell activation to repress cholesterol efflux.